113 related articles for article (PubMed ID: 9511968)
21. RNA-protein interactions in the Tat-trans-activation response element complex determined by site-specific photo-cross-linking.
Wang Z; Rana TM
Biochemistry; 1998 Mar; 37(12):4235-43. PubMed ID: 9521746
[TBL] [Abstract][Full Text] [Related]
22. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
[TBL] [Abstract][Full Text] [Related]
23. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
[TBL] [Abstract][Full Text] [Related]
24. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1.
Abbott KL; Archambault J; Xiao H; Nguyen BD; Roeder RG; Greenblatt J; Omichinski JG; Legault P
Biochemistry; 2005 Mar; 44(8):2716-31. PubMed ID: 15723517
[TBL] [Abstract][Full Text] [Related]
25. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
Murchie AI; Davis B; Isel C; Afshar M; Drysdale MJ; Bower J; Potter AJ; Starkey ID; Swarbrick TM; Mirza S; Prescott CD; Vaglio P; Aboul-ela F; Karn J
J Mol Biol; 2004 Feb; 336(3):625-38. PubMed ID: 15095977
[TBL] [Abstract][Full Text] [Related]
26. Solution structure of the HIV-2 TAR-argininamide complex.
Brodsky AS; Williamson JR
J Mol Biol; 1997 Apr; 267(3):624-39. PubMed ID: 9126842
[TBL] [Abstract][Full Text] [Related]
27. Detailed analysis of RNA-protein interactions within the bacterial ribosomal protein L5/5S rRNA complex.
Perederina A; Nevskaya N; Nikonov O; Nikulin A; Dumas P; Yao M; Tanaka I; Garber M; Gongadze G; Nikonov S
RNA; 2002 Dec; 8(12):1548-57. PubMed ID: 12515387
[TBL] [Abstract][Full Text] [Related]
28. Structure of RNA aptamer complexed with an RNA-binding peptide of Tat with aid of residue-specific 13C, 15N labeling.
Matsugami A; Tochio H; Niyada E; Tamura Y; Kudo M; Misono TS; Kumar P; Katahira M
Nucleic Acids Symp Ser (Oxf); 2005; (49):69-70. PubMed ID: 17150637
[TBL] [Abstract][Full Text] [Related]
29. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
[TBL] [Abstract][Full Text] [Related]
30. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
Zhao H; Li J; Xi F; Jiang L
FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
32. Identification of amino acids that promote specific and rigid TAR RNA-tat protein complex formation.
Edwards TE; Robinson BH; Sigurdsson ST
Chem Biol; 2005 Mar; 12(3):329-37. PubMed ID: 15797217
[TBL] [Abstract][Full Text] [Related]
33. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
[TBL] [Abstract][Full Text] [Related]
34. The 3D arrangement of the 23 S and 5 S rRNA in the Escherichia coli 50 S ribosomal subunit based on a cryo-electron microscopic reconstruction at 7.5 A resolution.
Mueller F; Sommer I; Baranov P; Matadeen R; Stoldt M; Wöhnert J; Görlach M; van Heel M; Brimacombe R
J Mol Biol; 2000 Apr; 298(1):35-59. PubMed ID: 10756104
[TBL] [Abstract][Full Text] [Related]
35. Equine infectious anemia virus transactivator is a homeodomain-type protein.
Willbold D; Metzger AU; Sticht H; Gallert KC; Voit R; Dank N; Bayer P; Krauss G; Goody RS; Rösch P
J Mol Biol; 1998 Apr; 277(4):749-55. PubMed ID: 9545368
[TBL] [Abstract][Full Text] [Related]
36. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
Elangovan B; Subramanian T; Chinnadurai G
J Virol; 1992 Apr; 66(4):2031-6. PubMed ID: 1548750
[TBL] [Abstract][Full Text] [Related]
37. Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein.
Huang HW; Wang KT
Biochem Biophys Res Commun; 1996 Oct; 227(2):615-21. PubMed ID: 8878561
[TBL] [Abstract][Full Text] [Related]
38. A docking and modelling strategy for peptide-RNA complexes: applications to BIV Tat-TAR and HIV Rev-RBE.
Srinivasan J; Leclerc F; Xu W; Ellington AD; Cedergren R
Fold Des; 1996; 1(6):463-72. PubMed ID: 9080192
[TBL] [Abstract][Full Text] [Related]
39. Circular dichroism studies suggest that TAR RNA changes conformation upon specific binding of arginine or guanidine.
Tan R; Frankel AD
Biochemistry; 1992 Oct; 31(42):10288-94. PubMed ID: 1384695
[TBL] [Abstract][Full Text] [Related]
40. Evidence for plant ribosomal 5S RNA involvement in elongation of polypeptide chain biosynthesis.
Shaikhin S; Sobkiewicz A; Barciszewski J; Twardowski T
Acta Biochim Pol; 1994; 41(1):57-62. PubMed ID: 8030375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
